[A new method of radiofrequency needle ablation of the prostate in the treatment of benign hyperplasia].
The authors present the results of a new transvesical approach for radiofrequency needle ablation of the prostate in 29 patients with benign prostatic hyperplasia (BPH). The ablation has been done using a new radiofrequency generator ESHFG-440-40-1 made in Russia. Upon 12-month follow-up urination normalized in 23 patients. This result is better than that after transurethral needle ablation. The transvesical needle ablation has no contradictions and can be used in a wide range of patients with BPH both in hospital and outpatient settings.